Plant ID: NPO16885
Plant Latin Name: Phonus arborescens
Taxonomy Genus: Phonus
Taxonomy Family: Asteraceae
NCBI TaxonomyDB:
121177
Plant-of-the-World-Online:
n.a.
HCAR2; |
Cytochrome P450 Enzymes: | CYP19A1; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 19 | CYP19A1 | Cytochrome P450 19A1 | P11511 | CHEMBL1978 |
Small molecule receptor (family A GPCR) | HCAR2 | Hydroxycarboxylic acid receptor 2 | Q8TDS4 | CHEMBL3785 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 2.380E-03 | 1.000E+00 | CYP19A1 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 3.517E-03 | 1.000E+00 | CYP19A1 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 4.654E-03 | 1.000E+00 | CYP19A1 |
MF | GO:0003824; catalytic activity | GO:0009055; electron transfer activity | 1.115E-02 | 1.000E+00 | CYP19A1 |
MF | GO:0005488; binding | GO:0020037; heme binding | 1.321E-02 | 1.000E+00 | CYP19A1 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09152 Endocrine system | hsa04913 | Ovarian steroidogenesis | 4.994E-03 | 1.158E-02 | CYP19A1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 5.792E-03 | 1.158E-02 | CYP19A1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04024 | cAMP signaling pathway | 1.980E-02 | 2.640E-02 | HCAR2 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 1.201E-01 | 1.201E-01 | CYP19A1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Breast cancer | C50 | CYP19A1; |
N00-N99: Diseases of the genitourinary system | Endometriosis | N80 | CYP19A1; |
C00-D49: Neoplasms | Advanced breast cancer | C50 | CYP19A1; |
C00-D49: Neoplasms | Hormonally-responsive breast cancer | C50 | CYP19A1; |
C00-D49: Neoplasms | Bladder cancer | C67 | CYP19A1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Hyperlipidaemia | E78 | HCAR2; |
N00-N99: Diseases of the genitourinary system | Prostate disease | N42.9 | CYP19A1; |
I00-I99: Diseases of the circulatory system | Acute ischemic stroke | I61-I63 | HCAR2; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | HCAR2; |
I00-I99: Diseases of the circulatory system | Cardiovascular disorder | I00-I99 | HCAR2; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Major depressive disorder | F32, F33, M32 | HCAR2; |
I00-I99: Diseases of the circulatory system | Arteriosclerosis | I70 | HCAR2; |
I00-I99: Diseases of the circulatory system | Atherosclerosis | I70 | HCAR2; |